Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
McKesson
Fish and Richardson
Moodys
Citi
Boehringer Ingelheim

Generated: May 20, 2019

DrugPatentWatch Database Preview

Dextroamphetamine sulfate - Generic Drug Details

« Back to Dashboard

What are the generic sources for dextroamphetamine sulfate and what is the scope of dextroamphetamine sulfate patent protection?

Dextroamphetamine sulfate is the generic ingredient in five branded drugs marketed by Impax Labs Inc, Able, Actavis Elizabeth, Mayne Pharma, Mylan Pharms Inc, Nesher Pharms, Specgx Llc, Vintage Pharms, Teva, Glaxosmithkline, Outlook Pharms, Tris Pharma Inc, Ani Pharms Inc, Arbor Pharms Llc, Aurolife Pharma Llc, Avanthi Inc, Barr, Epic Pharma Llc, Halsey, Lannett, Mast Mm, Novel Labs Inc, Nuvo Pharm, Purepac Pharm, Sandoz, Vintage Pharms Llc, Vitarine, Shire, and Ferndale Labs, and is included in thirty-seven NDAs. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for dextroamphetamine sulfate. Twenty-four suppliers are listed for this compound.

Pharmacology for dextroamphetamine sulfate
Medical Subject Heading (MeSH) Categories for dextroamphetamine sulfate

US Patents and Regulatory Information for dextroamphetamine sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth DEXTROAMPHETAMINE SULFATE dextroamphetamine sulfate CAPSULE, EXTENDED RELEASE;ORAL 203901-001 Nov 30, 2012 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Arbor Pharms Llc DEXTROAMPHETAMINE SULFATE dextroamphetamine sulfate TABLET;ORAL 090533-001 Oct 25, 2011 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Barr DEXTROAMPHETAMINE SULFATE dextroamphetamine sulfate TABLET;ORAL 040361-001 Jan 31, 2001 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Arbor Pharms Llc DEXTROAMPHETAMINE SULFATE dextroamphetamine sulfate TABLET;ORAL 090533-003 Oct 25, 2011 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Pharms Inc DEXTROAMPHETAMINE SULFATE dextroamphetamine sulfate CAPSULE, EXTENDED RELEASE;ORAL 206735-002 Jan 27, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Nuvo Pharm DEXTROAMPHETAMINE SULFATE dextroamphetamine sulfate TABLET;ORAL 210059-001 Oct 18, 2017 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
US Army
UBS
Argus Health
Teva
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.